Defining and managing imatinib resistance.

Abstract excerpt

While imatinib is highly effective therapy, with improving prospects over time for sustained remission and potential to severely limit or eliminate disease progression and transformation, a minority of patients either fail or respond suboptimally to imatinib; as well, disease eradication may not be possible with imatinib. Distinct patterns of resistance have evolved with the use of imatinib, and Abl kinase...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Benzamides
• Share to Disease Management
• Share to Drug Resistance, Neoplasm